<DOC>
	<DOC>NCT00193713</DOC>
	<brief_summary>Study of the long-term efficacy and safety of bifeprunox in the treatment of schizophrenia.</brief_summary>
	<brief_title>Bifeprunox in the Treatment of Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>diagnosis of schizophrenia understand nature of study able to be managed in outpatient setting for longterm bifeprunox treatment current primary diagnosis other than schizophrenia suicide risk diagnosis or history of substance abuse uncontrolled hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>double-blind study in the treatment of schizophrenia</keyword>
</DOC>